Collection
Drug Design reviews
- Submission status
- Open
- Open for submission from
- 06 November 2023
- Submission deadline
- Ongoing
The following articles were selected by the editors as some of the best review articles published in Medicinal Chemistry Research on drug design. This list is current to 1 October, 2023.
Articles (27 in this collection)
-
-
A guide for the synthesis of key nucleoside scaffolds in drug discovery
Authors (first, second and last of 4)
- Dinithi G. Rajapaksha
- Subhojit Mondal
- Michael W. Meanwell
- Content type: Review Article
- Published: 20 June 2023
- Pages: 1315 - 1333
-
The rise of targeting chimeras (TACs): next-generation medicines that preempt cellular events
Authors (first, second and last of 10)
- Scott Hollingsworth
- Scott Johnson
- Veerabahu Shanmugasundaram
- Content type: Review Article
- Published: 19 June 2023
- Pages: 1294 - 1314
-
A MIST conception: what has been learned from twenty years of human metabolite safety assessment?
Authors
- Debra Luffer-Atlas
- R. Scott Obach
- Dennis A. Smith
- Content type: Review Article
- Published: 13 June 2023
- Pages: 1933 - 1949
-
Utilizing mechanistic organic chemistry training to study drug metabolism in preclinical drug discovery/development
Authors
- Deepak Dalvie
- Amit S. Kalgutkar
- Content type: Review Article
- Published: 07 June 2023
- Pages: 1922 - 1932
-
Harnessing the necessary nitrogen atom in chemical biology and drug discovery
Authors
- Lewis D. Pennington
- Philip N. Collier
- Eamon Comer
- Content type: Review Article
- Published: 27 May 2023
- Pages: 1278 - 1293
-
An update on the discovery and development of reversible covalent inhibitors
Authors (first, second and last of 4)
- Faridoon
- Raymond Ng
- Jie Jack Li
- Content type: Review Article
- Published: 29 April 2023
- Pages: 1039 - 1062
-
The pyridazine heterocycle in molecular recognition and drug discovery
Authors
- Nicholas A. Meanwell
- Content type: Review Article
- Published: 15 March 2023
- Pages: 1853 - 1921
-
Medicinal chemistry insights into non-hydroxamate HDAC6 selective inhibitors
Authors (first, second and last of 4)
- Faridoon
- Yuqi Lavender Zha
- Jie Jack Li
- Content type: Review Article
- Published: 31 October 2022
- Pages: 1 - 14
-
Discovery of mobocertinib, a new irreversible tyrosine kinase inhibitor indicated for the treatment of non-small-cell lung cancer harboring EGFR exon 20 insertion mutations
Authors (first, second and last of 4)
- Jun Wang
- Daniel Lam
- Longqin Hu
- Content type: Review Article
- Published: 01 September 2022
- Pages: 1647 - 1662
-
The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
Authors
- Ryan P. Joyce
- Vivian W. Hu
- Jun Wang
- Content type: Review Article
- Published: 30 August 2022
- Pages: 1637 - 1646
-
Antimicrobial activity of quaternary ammonium salts: structure-activity relationship
Authors (first, second and last of 8)
- Mallikarjuna N. Nadagouda
- Pooja Vijayasarathy
- Changseok Han
- Content type: Review Paper
- Published: 02 July 2022
- Pages: 1663 - 1678
-
Molecular glues: enhanced protein-protein interactions and cell proteome editing
Authors (first, second and last of 4)
- Evita G. Weagel
- Jason M. Foulks
- Steven L. Warner
- Content type: Review Article
- Open Access
- Published: 12 May 2022
- Pages: 1068 - 1087
-
Evaluation of novel multifunctional organoselenium compounds as potential cholinesterase inhibitors against Alzheimer’s disease
Authors (first, second and last of 4)
- Dina A. Refaay
- Dalia M. Ahmed
- Saad Shaaban
- Content type: Original Research
- Published: 12 April 2022
- Pages: 894 - 904
-
Design, synthesis and biological evaluation of 8-aminoquinoline-1,2,3-triazole hybrid derivatives as potential antimicrobial agents
Authors (first, second and last of 4)
- Fatma Albayrak
- Mustafa Çiçek
- Irem Kulu
- Content type: Original Research
- Published: 07 March 2022
- Pages: 652 - 665
-
An insight into prodrug strategy for the treatment of Alzheimer’s disease
Authors (first, second and last of 6)
- Neha V. Bhilare
- Vinayak S. Marulkar
- Pramodkumar J. Shirote
- Content type: Review Article
- Published: 15 February 2022
- Pages: 383 - 399
-
Anticancer and antimicrobial activities of new thiazolyl-urea derivatives: gene expression, DNA damage, DNA fragmentation and SAR studies
Authors (first, second and last of 4)
- Farid M. Sroor
- Abdelmageed M. Othman
- Karima F. Mahrous
- Content type: Original Research
- Published: 24 January 2022
- Pages: 400 - 415
-
Semi-synthesis and cytotoxicity evaluation of pyrimidine, thiazole, and indole analogues of argentatins A–C from guayule (Parthenium argentatum) resin
Authors (first, second and last of 6)
- Chandrashekhar Madasu
- Ya-Ming Xu
- A. A. Leslie Gunatilaka
- Content type: Original Research
- Published: 17 January 2022
- Pages: 1088 - 1098
-
Isatin derivatives as broad-spectrum antiviral agents: the current landscape
Authors (first, second and last of 7)
- Tilal Elsaman
- Malik Suliman Mohamed
- Magdi Awadalla Mohamed
- Content type: Review Article
- Published: 13 January 2022
- Pages: 244 - 273
-
Synthesis and anticancer activity of novel hydrazone linkage-based aryl sulfonate derivatives as apoptosis inducers
Authors (first, second and last of 5)
- Sevil ÅženkardeÅŸ
- M. Ä°hsan Han
- Ş. Güniz Küçükgüzel
- Content type: Original Research
- Published: 12 January 2022
- Pages: 368 - 379
-
Design, synthesis, in vitro evaluation, and docking studies on ibuprofen derived 1,3,4-oxadiazole derivatives as dual α-glucosidase and urease inhibitors
Authors (first, second and last of 13)
- Saima Daud
- Obaid-ur-Rahman Abid
- Basit Niaz
- Content type: Original Research
- Published: 08 January 2022
- Pages: 316 - 336
-
Review on molnupiravir as a promising oral drug for the treatment of COVID-19
Authors
- Elham Zarenezhad
- Mahrokh Marzi
- Content type: Review Article
- Published: 03 January 2022
- Pages: 232 - 243
-
A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19
Authors
- Robert L. Chapman
- Shridhar V. Andurkar
- Content type: Review Article
- Published: 02 December 2021
- Pages: 40 - 51
-
Sulfur-containing therapeutics in the treatment of Alzheimer’s disease
Authors (first, second and last of 4)
- Haizhou Zhu
- Venkateshwara Dronamraju
- Swati S. More
- Content type: Review Article
- Published: 15 January 2021
- Pages: 305 - 352
-
Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
Authors
- P. Chellapandi
- S. Saranya
- Content type: Review Article
- Published: 31 July 2020
- Pages: 1777 - 1791
-
Rheostat positions: A new classification of protein positions relevant to pharmacogenomics
Authors (first, second and last of 5)
- Aron W. Fenton
- Braelyn M. Page
- Liskin Swint-Kruse
- Content type: Review Article
- Published: 07 June 2020
- Pages: 1133 - 1146
-
Drug–protein adducts: past, present, and future
Authors
- Thomas A. Baillie
- Content type: Review Article
- Published: 27 May 2020
- Pages: 1093 - 1104